Literature DB >> 9190520

[Structured care for stroke patients: stroke units and transmural stroke services].

M Limburg1, L J Kappelle.   

Abstract

Following the successful introduction of Coronary Care Units for patients after a myocardial infarction, Stroke Units were designed where the specialized care for patients who had suffered a stroke might be concentrated. A meta-analysis in 1993 indicated that patients indeed benefited from treatment in such a unit. Stroke is the third cause of death in the Netherlands, with a prevalence in people aged 55 and more of 3.5% in men and of 1.9% in women. A Stroke Unit is part of a hospital; a Transmural Stroke Service in which neurologists and general practitioners participate, may deliver the appropriate care in the appropriate setting: patients may quickly be admitted to the hospital, an outpatient clinic can limit unnecessary hospitalization, and the general practitioner supervises chronic home treatment. The possibilities are there, now they have to be implemented.

Entities:  

Mesh:

Year:  1997        PMID: 9190520

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Towards a better integrated stroke care: the development of integrated stroke care in the southern part of the Netherlands during the last 15 years (Special 10th Anniversary Edition paper).

Authors:  Ron Heijnen; Martien Limburg; Silvia Evers; George Beusmans; Trudy van der Weijden; Jos Schols
Journal:  Int J Integr Care       Date:  2012-05-25       Impact factor: 5.120

2.  Stroke service in The Netherlands: an exploratory study on effectiveness, patient satisfaction and utilisation of healthcare.

Authors:  H Rosendal; C A M Wolters; G H M I Beusmans; L P de Witte; J Boiten; H F J M Crebolder
Journal:  Int J Integr Care       Date:  2002-03-01       Impact factor: 5.120

3.  Survival of stroke patients after introduction of the 'Dutch Transmural Protocol TIA/CVA'.

Authors:  Leonie de Weerd; Feikje Groenhof; Boudewijn J Kollen; Klaas van der Meer
Journal:  BMC Fam Pract       Date:  2013-06-04       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.